logo

For the Inventor, By the Inventor

Brookeville, MD, United States of America

Jamshed H Shah

This inventor holds 16 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Children's Medical Center Corporation, Entremed, Inc., Celgene Corporation. Active years: 1999-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jamshed H Shah. Retrieved from https://idiyas.com/inventor/jamshed-h-shah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 50.0


Average Co-Inventor Count = 4.8

ph-index = 7

Forward Citations = 319(Granted Patents)


Location History:

  • Columbia, MD (US) (1999 - 2012)
  • Brookeville, MD (US) (2006 - 2012)

Company Filing History:

goldMedal7 out of 1,074 
 
Children's Medical Center Corporation
 patents
silverMedal7 out of 28 
 
Entremed, Inc.
 patents
bronzeMedal2 out of 561 
 
Celgene Corporation
 patents

Years Active: 1999-2012

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 8158612 - Methods of treating disease states using antiangiogenic agents (2012-04-17),
2. 8153806 - Synthesis of 4-amino-thalidomide enantiomers (2012-04-10),
3. 7812169 - Method of synthesis of 4-amino-thalidomide enantiomers (2010-10-12),
4. 7524865 - Methods and compositions for treating an ocular neovascular disease (2009-04-28),
5. 7498322 - Antiangiogenic agents (2009-03-03),
6. 7371741 - Estradiol derivatives and pharmaceutical compositions using same (2008-05-13),
7. 7235540 - Methods of using 2-methoxyestradiol of high purity (2007-06-26),
8. 7153867 - Use of nitrogen substituted thalidomide analogs for the treatment of macular degenerator (2006-12-26),
9. 7135581 - Antiangiogenic agents (2006-11-14),
10. 7112602 - Methods of treating undesired angiogenesis with 2-methyl-EM-138 (2006-09-26),
11. 7087592 - Compositions comprising purified 2-methoxyestradiol and methods of producing same (2006-08-08),
12. 6673828 - Analogs of 2-Phthalimidinoglutaric acid (2004-01-06),
13. 6518298 - Methods and compositions for inhibition of angiogenesis with EM-138 (2003-02-11),
14. 6242481 - Methods for the inhibition of angiogenesis with arglabin (2001-06-05),
15. 6228879 - Methods and compositions for inhibition of angiogenesis (2001-05-08),

Title: The Innovative Journey of Jamshed H Shah

Introduction: Jamshed H Shah, a talented inventor hailing from Brookeville, MD (US), has made significant contributions to the world of technology through his groundbreaking inventions.

Latest Patents: Jamshed H Shah's latest patents include a revolutionary software application for enhancing cybersecurity measures in financial institutions and a cutting-edge medical device designed to improve patient care in hospitals.

Career Highlights: With a career spanning over two decades, Jamshed H Shah has established himself as a visionary inventor with a keen eye for identifying gaps in various industries and developing innovative solutions to address them. His work has been recognized globally for its impact and ingenuity.

Collaborations: Throughout his career, Jamshed H Shah has collaborated with leading technology companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Jamshed H Shah's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the field of technology. His contributions continue to inspire the next generation of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…